Posters & Publications Peak Bio, Inc. Presents Preclinical Data Highlighting Potential of Differentiated Trop2 ADC at the 2023 AACR Annual Meeting DOWNLOAD POSTER Peak Bio, Inc introduces a novel immunostimulatory ADC payload targeting RNA splicing and demonstrates tumoricidal properties of a proof-of concept Her2 ADC at the 2021 AACR annual meeting DOWNLOAD POSTER
